Arca biopharma retains ladenburg thalmann to support strategic options review

Westminster, colo., may 05, 2022 (globe newswire) -- arca biopharma, inc. (nasdaq: abio) today announced that it has retained ladenburg thalmann & co. inc. to act as its financial advisor.

ABIO Ratings Summary

ABIO Quant Ranking